Replies to post #242044 on Elite Pharmaceuticals Inc (ELTP)

[jtf3]

Have you seen the numbers

[jour_trader]

Let me help you. I believe in the LT prospects, but this quarter as reflected in the financials sucks. PERIOD.
Nice try though.

No momentum in generics. Revenues 6% growth over LY?! 2 straight quarters where rev has dropped. Gross profit was hammered. 3.8M cash bleed.

12M more shares diluted. At least that has slowed down a little.

Selling of NOL's was actually decent as the 8% discount wasn't too bad.

This is reality in black & white for better or worse.

[freegriff]

good and bad. Clearly we prepared for the coming winter. Hard not to see a squeeze and slashed R&D. I'm sure that has changed now. All focus back on sequestox.

Need to know why our margins are getting squeezed. In the future, without a substantially differentiated product, $100mill in revenue won't happen if we're packing dust for 10% off the top.